Anemia news from FierceHealthcare
NewsHHS: Hospitals need management programs for blood transfusions
U.S. hospitals need to develop "patient blood management" programs to reduce the number of unneeded blood transfusions given across the country, according to a recent Associated Press story. The Read more...
DaVita subpoenaed by HHS Inspector General
Renal-care firm DaVita has received a subpoena from the HHS Inspector General's office asking for documents related to its use of vitamin D and anemia drugs. The company, which disclosed the request Read more...
Hospitals cutting back on transfusions
With blood costs high, and concerns over blood safety growing, hospitals are developing tougher rules for when it's appropriate to provide transfusions. They're also riding herd on doctors to make Read more...
| Press ReleasesOrSense's Non Invasive Hemoglobin Monitor has the Potential to Enhance Recruitment of Blood DonorsIn a statement on the World Blood Donors Day, Dr. Emma Castro, CEO of the Transfusion Center of the Spanish Red Cross in Madrid, stated, "Our donors are very excited about the implementation of the Read more >> While Changes in the Bone and Mineral Metabolism Market Due to Bundling Are Subtle Relative to the Renal Anemia Market, ChEXTON, Penn.--(BUSINESS WIRE)-- The new dialysis bundled payment system that went into effect on January 1, 2011 has had a significant impact on the management of renal anemia according to a number Read more >> bluebird bio Awarded up to $4.2 Million from the French Muscular Dystrophy Association for Continued Development of Gene TCAMBRIDGE, Mass.--(BUSINESS WIRE)-- bluebird bio, an emerging leader in the development of innovative gene therapies for severe genetic disorders, today announced that it has entered into an Read more >> WPCCU Begins Credit Unions for Kids FundraiserProceeds Will Go to Childrens Hospital Los Angeles LOS ANGELES--(BUSINESS WIRE)-- WPCCU is holding a November-long fundraiser in association with Credit Unions for Kids to benefit Childrens Hospital Read more >> AMAG Pharmaceuticals, Inc. to Present at Canaccord Genuity 30th Annual Global Growth ConferenceLEXINGTON, Mass.--(BUSINESS WIRE)-- AMAG Pharmaceuticals, Inc. (NASDAQ: AMAG) today announced that management will present an overview of the company at the Canaccord Genuity 30th Annual Global Read more >> |
